Related Posts
Learn about the company, the projected growth of the business and how Legion makes money for its shareholders and investors. …
FinTech Enabled Specialized Lender Serves Underfinanced Business and Real Estate Developers ORLANDO, FL., April 21, 2022 — Legion Capital Corporation…
FinTech Enabled Specialized Lender Serves Underfinanced Business and Real Estate Developers ORLANDO, FL., June 22, 2022 — Legion Capital…
Legion Capital (Ticker Symbol: LGCP) is a FinTech enabled, publicly traded specialized business lender providing growth capital to small and…
Private Equity FinTech Lender continues to excel with expanding real estate market in the United States ORLANDO, FL., December 9th,…
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com Orlando,…
Orlando, FL – Legion Capital Corporation (Ticker Symbol: LGCP), is a FinTech enabled, publicly traded specialized business lender providing growth capital…
FinTech driven Specialized Lender posts first quarterly profit as a public company Orlando, Florida — June 3, 2021 — Legion…
An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 15, 2021 (GLOBE NEWSWIRE) — A very strong hire for Legion Capital Corp (OTCQX:…
FinTech Enabled Specialized Lender Finances Business and Real Estate Developers in Florida Housing Market ORLANDO, FL., August 2, 2022…
Listen in as Legion Capital CMO Shane Hackett and CTO J. Bradley Hilton discuss Financial Technology, Past and Present…
Legion Capital CTO J. Bradley Hilton Discusses AI, GoLegion and Cryptocurrencies in Benzinga Exclusive Article ORLANDO, FL / April 27,…
Join Legion Capital Chairman & CEO James Byrd for the final video of a three part video series on “Legion…
ORLANDO, Fla., March 10, 2021 (GLOBE NEWSWIRE) — Legion Capital Corporation (OTCQX: LGCP), a FinTech enabled private equity firm, is pleased…
Legion Capital CEO James Byrd discusses cryptocurrency, Bitcoin, Ethereum, and it’s future vision in an exclusive interview featured on OTC…